1110 POSTER Early change of F-18 FDG uptake after chemotherapy in aggressive hodgkin's lymphoma and non-Hodgkin's lymphoma: the different pattern of F-18 FDG uptake between aggressive Hodgkin's lymphoma and non-Hodgkin's lymphoma

首页> 外文期刊>European Journal of Cancer Supplements >1110 POSTER Early change of F-18 FDG uptake after chemotherapy in aggressive hodgkin's lymphoma and non-Hodgkin's lymphoma: the different pattern of F-18 FDG uptake between aggressive Hodgkin's lymphoma and non-Hodgkin's lymphoma

【24h】

1110 POSTER Early change of F-18 FDG uptake after chemotherapy in aggressive hodgkin's lymphoma and non-Hodgkin's lymphoma: the different pattern of F-18 FDG uptake between aggressive Hodgkin's lymphoma and non-Hodgkin's lymphoma

机译：1110海报侵略性霍奇金淋巴瘤和非霍奇金淋巴瘤化疗后F-18 FDG摄取的早期变化：侵略性霍奇金淋巴瘤和非霍奇金淋巴瘤之间F-18 FDG吸收的模式不同

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2005年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma [J] . Tatsuo Torizuka, Fumitoshi Nakamura, Toshihiko Kanno, European journal of nuclear medicine . 2004,第1期

机译：FDG-PET对侵袭性非霍奇金淋巴瘤和霍奇金淋巴瘤的早期治疗监测
2. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). [J] . Wunderlich A, Kloess M, Reiser M, Annals of oncology: official journal of the European Society for Medical Oncology . 2003,第6期

机译：2周和3周的CHOP和CHOEP化疗对侵袭性非霍奇金淋巴瘤的实用性和急性血液学毒性：德国高级非霍奇金淋巴瘤研究小组（DSHNHL）的NHL-B试验结果。
3. Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). [J] . Zwick C, Birkmann J, Peter N, Annals of hematology . 2008,第9期

机译：推注和依托泊苷的等效毒性：德国高级别非霍奇金淋巴瘤研究组（DSHNHL）使用CEMP方案（顺铂，依托泊苷，米托蒽醌）治疗顽固性或复发性侵袭性非霍奇金淋巴瘤的老年患者的多中心随机试验结果和泼尼松）。
4. Development of Single Domain Antibodies for Diagnosis and Treatment of Naturally Occurring Canine Lymphoma: An Animal Model for Human Non-Hodgkin Lymphoma [C] . Joana Dias, Solange Gil, Belmira Carrapico, PEGS . 2015

机译：天然犬淋巴瘤诊断和治疗单结构域抗体的发展：人非霍奇金淋巴瘤的动物模型
5. Estimation of G-CSF effectiveness in reducing neutropenia hospitalization among Non-Hodgkin's Lymphoma (NHL) patients treated with anthracycline-based chemotherapy. [D] . Pan, Xiaoyun. 2010

机译：估计G-CSF在以蒽环类为基础的化学疗法治疗的非霍奇金淋巴瘤（NHL）患者中减少中性粒细胞减少症住院的有效性。
6. Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation [O] . Yun Soo Park, Seok Mo Lee, Ji Sun Park, 2018

机译：评估初步分期F-18 FDG PET / CT对干细胞移植非霍奇金恶性淋巴瘤患者预后的预测能力
7. Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation [O] . Yun Soo Park, Seok Mo Lee, Ji Sun Park, 2017

机译：评估初始分期F-18 FDG PET / CT的预测能力，用于患有干细胞移植的非霍奇金恶性淋巴瘤患者预后

1110 POSTER Early change of F-18 FDG uptake after chemotherapy in aggressive hodgkin's lymphoma and non-Hodgkin's lymphoma: the different pattern of F-18 FDG uptake between aggressive Hodgkin's lymphoma and non-Hodgkin's lymphoma

著录项

相似文献

相关主题

期刊订阅